Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health Corporation    CVS

CVS HEALTH CORPORATION (CVS)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 Analysis summary4-Traders Strategies
Summary
  • The company has solid fundamentals for a short-term investment strategy.
Strengths
  • The close medium term support offers good timing for purchasing the stock.
  • The company shows low valuation levels, with an enterprise value at 0.45 times its sales.
  • The company's attractive earnings multiples are brought to light by a P/E ratio at 12.7 for the current year.
  • This company will be of major interest to investors in search of a high dividend stock.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
  • According to forecast, a sluggish sales growth is expected for the next fiscal years.
  • Below the resistance at 70.55 USD, the stock shows a negative configuration when looking looking at the weekly chart.
Ratings chart
Sector Drug Retailers - NEC
1st jan.Capitalisation (M$)Investor Rating
CVS HEALTH CORPORATION-9.30%66 855
WALGREENS BOOTS ALLIANCE-9.13%65 440
EXPRESS SCRIPTS HOLDING CO0.00%42 887
MCKESSON CORPORATION-3.18%31 155
AMERISOURCEBERGEN-7.68%19 138
CARDINAL HEALTH-12.96%17 098
MATSUMOTOKIYOSHI HOLDINGS C..22.53%5 629
WELCIA HOLDINGS CO LTD21.43%5 627
MEDIPAL HOLDINGS CORP13.29%5 603
JOINTOWN PHARMACEUTICAL GRO..-3.96%5 359
SUZUKEN CO., LTD.8.97%4 755
DASHENLIN PHARMACEUTICAL GR..33.18%4 316
CLICKS GROUP LTD17.23%4 235
CHINA NATIONAL MEDICINES CO..3.42%3 458
CHINA NATIONAL ACCORD MEDIC..--.--%3 419
YIFENG PHARMACY CHAIN CO LT..31.97%3 414
More Results
Financials ($)
Sales 2018 189 B
EBIT 2018 9 961 M
Net income 2018 5 331 M
Debt 2018 19 170 M
Yield 2018 3,08%
P/E ratio 2018 12,70
P/E ratio 2019 9,91
EV / Sales 2018 0,46x
EV / Sales 2019 0,42x
Capitalization 66 855 M
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
Chart CVS HEALTH CORPORATION
Duration : Period : Day
CVS Health Corporation Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Duration : Period : Week
CVS Health Corporation Technical Analysis Chart | CVS | US1266501006 | 4-Traders